Advancing African Medicines Agency through Global Health Diplomacy for an Equitable Pan-African Universal Health Coverage: A Scoping Review

The African continent is home to 15% of the world’s population and suffers from a disease burden of more than 25% globally. In this COVID-19 era, the high burden and mortality are further worsened due to inequities, inequalities such as inadequate health systems, scarce financial and human resources...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Vijay Kumar Chattu, Vishal B. Dave, K. Srikanth Reddy, Bawa Singh, Biniyam Sahiledengle, Demisu Zenbaba Heyi, Cornelius Nattey, Daniel Atlaw, Kioko Jackson, Ziad El-Khatib, Akram Ali Eltom
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	African Medicines Agency health diplomacy equity intellectual property rights universal health coverage COVID-19 Medicine R
Acceso en línea:	https://doaj.org/article/877b861a92644be4aad6974ae94a58c0
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:877b861a92644be4aad6974ae94a58c0
record_format	dspace
spelling	oai:doaj.org-article:877b861a92644be4aad6974ae94a58c02021-11-25T17:48:00ZAdvancing African Medicines Agency through Global Health Diplomacy for an Equitable Pan-African Universal Health Coverage: A Scoping Review10.3390/ijerph1822117581660-46011661-7827https://doaj.org/article/877b861a92644be4aad6974ae94a58c02021-11-01T00:00:00Zhttps://www.mdpi.com/1660-4601/18/22/11758https://doaj.org/toc/1661-7827https://doaj.org/toc/1660-4601The African continent is home to 15% of the world’s population and suffers from a disease burden of more than 25% globally. In this COVID-19 era, the high burden and mortality are further worsened due to inequities, inequalities such as inadequate health systems, scarce financial and human resources, as well as unavailability of inexpensive medicines of good quality, safety, and efficacy. The Universal Health Coverage ensures that people have access to high-quality essential health services, secure, reliable, and affordable essential medicines and vaccines, as well as financial security. This paper aimed at addressing the critical need for a continental African Medicines Agency (AMA) in addressing the inequities and the role of global health diplomacy in building consensus to support the ratification of the Treaty of AMA. A literature review was done in Scopus, Web of Science, MEDLINE/PubMed, and Google Scholar search engine to identify the critical literature in the context of study objectives. All the articles published after 2015 till 2021 in the context of AMA were included. African Health Strategy 2016–2030 highlighted the importance of an African regulatory mechanism for medicines and medical products. Through global health diplomacy (GHD), the African Union and its partners can negotiate and cooperate in providing infrastructural, administrative, and regulatory support for establishing the AMA. The paper emphasizes the South–South cooperation and highlights the contributions of India and China in the supply of medicines and vaccines to Africa. A strong AMA created through GHD can be a vital instrument in utilizing Trade-Related Aspects of Intellectual Property Rights (TRIPS) flexibilities extension and an ideal partner for European and other regional regulatory authorities seeking to stem the tide of counterfeit, sub-standard, or fake products.Vijay Kumar ChattuVishal B. DaveK. Srikanth ReddyBawa SinghBiniyam SahiledengleDemisu Zenbaba HeyiCornelius NatteyDaniel AtlawKioko JacksonZiad El-KhatibAkram Ali EltomMDPI AGarticleAfrican Medicines Agencyhealth diplomacyequityintellectual property rightsuniversal health coverageCOVID-19MedicineRENInternational Journal of Environmental Research and Public Health, Vol 18, Iss 11758, p 11758 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	African Medicines Agency health diplomacy equity intellectual property rights universal health coverage COVID-19 Medicine R
spellingShingle	African Medicines Agency health diplomacy equity intellectual property rights universal health coverage COVID-19 Medicine R Vijay Kumar Chattu Vishal B. Dave K. Srikanth Reddy Bawa Singh Biniyam Sahiledengle Demisu Zenbaba Heyi Cornelius Nattey Daniel Atlaw Kioko Jackson Ziad El-Khatib Akram Ali Eltom Advancing African Medicines Agency through Global Health Diplomacy for an Equitable Pan-African Universal Health Coverage: A Scoping Review
description	The African continent is home to 15% of the world’s population and suffers from a disease burden of more than 25% globally. In this COVID-19 era, the high burden and mortality are further worsened due to inequities, inequalities such as inadequate health systems, scarce financial and human resources, as well as unavailability of inexpensive medicines of good quality, safety, and efficacy. The Universal Health Coverage ensures that people have access to high-quality essential health services, secure, reliable, and affordable essential medicines and vaccines, as well as financial security. This paper aimed at addressing the critical need for a continental African Medicines Agency (AMA) in addressing the inequities and the role of global health diplomacy in building consensus to support the ratification of the Treaty of AMA. A literature review was done in Scopus, Web of Science, MEDLINE/PubMed, and Google Scholar search engine to identify the critical literature in the context of study objectives. All the articles published after 2015 till 2021 in the context of AMA were included. African Health Strategy 2016–2030 highlighted the importance of an African regulatory mechanism for medicines and medical products. Through global health diplomacy (GHD), the African Union and its partners can negotiate and cooperate in providing infrastructural, administrative, and regulatory support for establishing the AMA. The paper emphasizes the South–South cooperation and highlights the contributions of India and China in the supply of medicines and vaccines to Africa. A strong AMA created through GHD can be a vital instrument in utilizing Trade-Related Aspects of Intellectual Property Rights (TRIPS) flexibilities extension and an ideal partner for European and other regional regulatory authorities seeking to stem the tide of counterfeit, sub-standard, or fake products.
format	article
author	Vijay Kumar Chattu Vishal B. Dave K. Srikanth Reddy Bawa Singh Biniyam Sahiledengle Demisu Zenbaba Heyi Cornelius Nattey Daniel Atlaw Kioko Jackson Ziad El-Khatib Akram Ali Eltom
author_facet	Vijay Kumar Chattu Vishal B. Dave K. Srikanth Reddy Bawa Singh Biniyam Sahiledengle Demisu Zenbaba Heyi Cornelius Nattey Daniel Atlaw Kioko Jackson Ziad El-Khatib Akram Ali Eltom
author_sort	Vijay Kumar Chattu
title	Advancing African Medicines Agency through Global Health Diplomacy for an Equitable Pan-African Universal Health Coverage: A Scoping Review
title_short	Advancing African Medicines Agency through Global Health Diplomacy for an Equitable Pan-African Universal Health Coverage: A Scoping Review
title_full	Advancing African Medicines Agency through Global Health Diplomacy for an Equitable Pan-African Universal Health Coverage: A Scoping Review
title_fullStr	Advancing African Medicines Agency through Global Health Diplomacy for an Equitable Pan-African Universal Health Coverage: A Scoping Review
title_full_unstemmed	Advancing African Medicines Agency through Global Health Diplomacy for an Equitable Pan-African Universal Health Coverage: A Scoping Review
title_sort	advancing african medicines agency through global health diplomacy for an equitable pan-african universal health coverage: a scoping review
publisher	MDPI AG
publishDate	2021
url	https://doaj.org/article/877b861a92644be4aad6974ae94a58c0
work_keys_str_mv	AT vijaykumarchattu advancingafricanmedicinesagencythroughglobalhealthdiplomacyforanequitablepanafricanuniversalhealthcoverageascopingreview AT vishalbdave advancingafricanmedicinesagencythroughglobalhealthdiplomacyforanequitablepanafricanuniversalhealthcoverageascopingreview AT ksrikanthreddy advancingafricanmedicinesagencythroughglobalhealthdiplomacyforanequitablepanafricanuniversalhealthcoverageascopingreview AT bawasingh advancingafricanmedicinesagencythroughglobalhealthdiplomacyforanequitablepanafricanuniversalhealthcoverageascopingreview AT biniyamsahiledengle advancingafricanmedicinesagencythroughglobalhealthdiplomacyforanequitablepanafricanuniversalhealthcoverageascopingreview AT demisuzenbabaheyi advancingafricanmedicinesagencythroughglobalhealthdiplomacyforanequitablepanafricanuniversalhealthcoverageascopingreview AT corneliusnattey advancingafricanmedicinesagencythroughglobalhealthdiplomacyforanequitablepanafricanuniversalhealthcoverageascopingreview AT danielatlaw advancingafricanmedicinesagencythroughglobalhealthdiplomacyforanequitablepanafricanuniversalhealthcoverageascopingreview AT kiokojackson advancingafricanmedicinesagencythroughglobalhealthdiplomacyforanequitablepanafricanuniversalhealthcoverageascopingreview AT ziadelkhatib advancingafricanmedicinesagencythroughglobalhealthdiplomacyforanequitablepanafricanuniversalhealthcoverageascopingreview AT akramalieltom advancingafricanmedicinesagencythroughglobalhealthdiplomacyforanequitablepanafricanuniversalhealthcoverageascopingreview
_version_	1718411995891367936

Advancing African Medicines Agency through Global Health Diplomacy for an Equitable Pan-African Universal Health Coverage: A Scoping Review

Ejemplares similares